Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock

🌐 Investing.com (Cyprus) —
Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock

AI Summary

Rapport Therapeutics CEO Abraham Ceesay sold company stock valued at $143,272. The report concerns an insider transaction in the biotechnology firm's shares.

Markets Deals Health Rapport Therapeutics Abraham Ceesay CEO insider sale stock transaction biotechnology

Read original source →